Improving the Quality of Life of Latin American Patients
M8 provides healthcare professionals and patients with access to proven treatments they need to thrive. We serve as a comprehensive source of expertise in each of the following therapeutic areas.
Central Nervous System
- Mokbio®(Lactobacillus plantarum 128)
- Haldol®(Haloperidol )
- Nabota®(Botulinum Toxin type A)
- Reminyl®(Galantamine Bromhide)
Reliable, Convenient Service and Support for Professionals and Patients
Partner with Us
From go-to-market strategy and registration to access and long-term market presence, M8 is a purpose-built biopharmaceutical platform that supports the entire development-commercialization continuum.
Our Commitment to Latin America
Six core values guide us on our mission to provide support to the patients and healthcare professionals of Latin America.
Hypertension: DILATREND® is indicated for the management of arterial hypertension, alone or in association with other antihypertensive agents (eg, calcium channel blockers and diuretics). Heart failure: Unless there is a contraindication, DILATREND® is indicated in all patients with mild, moderate and severe congestive heart failure (CHF) of ischemic and non-ischemic etiology in combination with standard therapy (inhibitor of the converting enzyme angiotensin, diuretics with or without digitalis).